BeStock  
Stocks › Biotechnology › IRON

Disc Medicine IRON

US equityMarket cap rank #2644Biotechnology
$63.33 −$1.18 (-1.83%)
Pre-market · Oct 6, 4:10 am ET · After hours $63.33 0.00%
Open$65.13
Prev close$64.51
Day range$63.01 – $65.57
Volume456.3K
Market cap$2.43B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, not just today’s reading.

Technical signals

Trend readStrong downtrend

1 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-7.1%BearishTrading below the 20-day average of $68.17
Price vs 50-day average-15.2%BearishTrading below the 50-day average of $74.67
Price vs 200-day average-11.6%BearishTrading below the 200-day average of $71.67
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)27.9NeutralOversold territory (30 or below); selling this heavy often eases
MACD (12,26,9)-3.30BearishMACD line is below its signal line
Bollinger band position19%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$68.17-7.1%
50-day SMA$74.67-15.2%
200-day SMA$71.67-11.6%

Recent price levels

LevelPrice
20-day high$79.13
20-day low$63.01
60-day high$83.63
60-day low$63.01
Upper Bollinger band$75.92
Lower Bollinger band$60.43

The 50-day average is currently 4.2% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility29.9%
Average true range4.00% of price
Max drawdown (1y)-40.5%
Volume (10d vs 90d)1.07x

Discussion

No comments yet — be the first to weigh in on IRON.

Leave a comment

Scroll to Top